Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-26

Clinical Trial Update: Precision Administration of Anti-thymocyte Globulin With or Without Verapamil [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating precision administration of anti-thymocyte globulin with or without verapamil for Type 1 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thymoglobulin (rabbit anti-thymocyte globulin)
  • Verapamil (verapamil)

Snippet

Sponsor: University of Florida | Conditions: Type 1 Diabetes | Phase 2 | Status: RECRUITING